Oleoylethanolamide: Effects on hypothalamic transmitters and gut peptides regulating food intake

Neuropharmacology

Volumn 60, Issue 4, 2011, Pages 593-601

  Serrano, Antonia ^a   Pavón, Francisco Javier ^a   Tovar, Sulay ^b   Casanueva, Felipe ^c,d   Señarís, Rosa ^b   Diéguez, Carlos ^b   Rodríguez De Fonseca, Fernando ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

AgRP; CART; Hypothalamus; Monoamines; NPY; Satiety

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ADIPONECTIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; DOPAMINE; GHRELIN; MESSENGER RNA; N OLEOYLETHANOLAMINE; NORADRENALIN; PEPTIDE YY; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEEDING BEHAVIOR; FOOD INTAKE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; MALE; MONOAMINERGIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADIPONECTIN; AGOUTI-RELATED PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE; EATING; FEEDING BEHAVIOR; GHRELIN; HYDROXYINDOLEACETIC ACID; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; NERVE TISSUE PROTEINS; NEUROPEPTIDE Y; NOREPINEPHRINE; OLEIC ACIDS; PEPTIDE YY; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; SEROTONIN;

EID: 79251595623     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.12.007     Document Type: Article

References (46)

1. R.L. Battherham, M.A. Cowley, C.J. Small, H. Herzog, M.A. Cohen, C.L. Dakin, A.M. Wren, A.E. Brynes, M.J. Low, M.A. Ghatei, R.D. Cone, and S.R. Bloom Gut hormone PYY (3-36) physiologically inhibits food intake Nature 418 2002 650 654
2. A.H. Berg, T.P. Combs, X. Du, M. Brownlee, and P.E. Scherer The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nat. Med. 7 2001 947 953
3. H.R. Berthoud, A. Jedrzejewska, and T.L. Powley Simultaneous labeling of vagal innervation of the gut and afferent projections from the visceral forebrain with dil injected into the dorsal vagal complex in the rat J. Comp. Neurol. 301 1990 65 79
4. L. Brunetti, G. Orlando, C. Ferrante, A. Chiavaroli, and M. Vacca Peptide YY (3-36) inhibits dopamine and norepinephrine release in the hypothalamus Eur. J. Pharmacol. 519 2005 48 51
5. L. Brunetti, G. Orlando, B. Michelotto, L. Recinella, and M. Vacca Cocaine- and amphetamine - regulated transcript peptide (55-102) and thyrotropin releasing hormone inhibit hypothalamic dopamine release Eur. J. Pharmacol. 409 2000 103 107
6. L. Brunetti, B. Michelotto, G. Orlando, and M. Vacca Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings Eur. J. Pharmacol. 372 1999 237 240
7. H. Cadas, E. di Tomaso, and D. Piomelli Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain J. Neurosci. 17 1997 1226 1242
8. P.D. Cani, M.L. Montoya, A.M. Neyrinck, N.M. Delzenne, and D.M. Lambert Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide Br. J. Nutr. 92 2004 757 761
9. D.E. Cummings, J.Q. Purnell, R.S. Frayo, K. Schmidova, B.E. Wisse, and D.S. Weigle A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans Diabetes 50 2001 1714 1719
10. V. Di Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J.C. Schwartz, and D. Piomelli Formation and inactivation of endogenous cannabinoid anandamide in central neurons Nature 372 1994 686 691
11. C.F. Elias, C.E. Lee, J.F. Kelly, R.S. Ahima, M. Kuhar, C.B. Saper, and J.K. Elmquist Characterization of CART neurons in the rat and human hypothalamus J. Comp. Neurol. 432 1 2001 1 19
12. J.K. Elmquist, C.F. Elias, and C.B. Saper From lesions to leptin: hypothalamic control of food intake and body weight Neuron 22 1999 221 232
13. J.M. Friedman Leptin, leptin receptors and the control of body weight Nutr. Rev. 56 1998 38 46
14. J. Fruebis, T.S. Tsao, S. Javorschi, D. Ebbets-Reed, M.R. Erickson, F.T. Yen, B.E. Bihain, and H.F. Lodish Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice Proc. Natl. Acad. Sci. U.S.A. 98 2001 2005 2010
15. J. Fu, G. Astarita, S. Gaetani, J. Kim, B.F. Cravatt, K. Mackie, and D. Piomelli Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine J. Biol. Chem. 282 2 2007 1518 1528
16. J. Fu, S. Gaetani, F. Oveisi, J. Lo Verme, A. Serrano, F. Rodríguez De Fonseca, A. Rosengarth, H. Luecke, B. di Giacomo, G. Tarzia, and D. Piomelli Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α Nature 425 2003 90 93
17. S. Gaetani, J. Fu, T. Cassano, P. Dipasquale, A. Romano, L. Righetti, S. Cianci, L. Laconca, E. Giannini, S. Scaccianoce, J. Mairesse, V. Cuomo, and D. Piomelli The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin J. Neurosci. 30 24 2010 8096 8101
18. R. Gómez, M. Navarro, B. Ferrer, J.M. Trigo, A. Bilbao, I. Del Arco, A. Cippitelli, F. Nava, D. Piomelli, and F. Rodríguez de Fonseca A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding J. Neurosci. 22 2002 9612 9617
19. C. González-Yanes, A. Serrano, F.J. Bermúdez-Silva, M. Hernández-Dominguez, M.A. Páez-Ochoa, F. Rodríguez de Fonseca, and V. Sánchez-Margalet Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways Am. J. Physiol. Endocrinol. Metab. 289 2005 923 929
20. M. Guzmán, J. Lo Verme, J. Fu, F. Oveisi, C. Blázquez, and D. Piomelli Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor α (PPAR- α) J. Biol. Chem. 279 2004 27849 27854
21. E. Hu, P. Liang, and B.M. Spiegelman AdipoQ is a novel adipose-specific gene dysregulated in obesity J. Biol. Chem. 271 1996 10697 10703
22. S.P. Kalra, M.G. Dube, S. Pu, B. Xu, T.L. Horvath, and P.S. Kalra Interacting appetite-regulating pathways in the hypothalamic regulation of body weight Endocr. Rev. 20 1999 68 100
23. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 1999 656 660
24. P. Kristensen, M.E. Judge, L. Thim, U. Ribel, K.N. Christjansen, B.S. Wulff, J.T. Clausen, P.B. Jensen, O.D. Madsen, N. Vrang, P.J. Larsen, and S. Hastrup Hypothalamic CART is a new anorectic peptide regulated by leptin Nature 393 1998 72 76
25. M. López, L.M. Seoane, M.C. García, C. Diéguez, and R. Señarís Neuropeptide Y, but not agouti-related peptide or melanin-concentrating hormone, is a target peptide for orexin-A feeding actions in the rat hypothalamus Neuroendocrinology 75 2002 34 44
26. P. Oliver, J. Ribot, A.M. Rodríguez, J. Sánchez, C. Picó, and A. Palou Resistin as a putative modulator of insulin action in the daily feeding/fasting rhythm Pflugers Arch. 452 2006 260 267
27. H.A. Overton, A.J. Babbs, S.M. Doel, M.C.T. Fyfe, L.S. Gardner, G. Griffin, H.C. Jackson, M.J. Procter, C.M. Rasamison, M. Tang-Christensen, P.S. Widdowson, G.M. Williams, and C. Reynet Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small molecule hypophagic agents Cell Metab. 3 2006 167 175
28. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1998 Academic Press Sydney Australia
29. K. Proulx, D. Cota, T.R. Castaneda, M.H. Tschop, D.A. D'Alessio, P. Tso, S.C. Woods, and R.J. Seeley Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 3 2005 729 737
30. E.J. Ramos, M.M. Meguid, A.C. Campos, and J.C. Coelho Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation Nutrition 21 2005 269 279
31. F. Rodriquez de Fonseca, M. Navarro, E. Alvarez, I. Roncero, J.A. Chowen, O. Maestre, R. Gómez, R.M. Muñoz, J. Eng, and E. Blázquez Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats Metabolism 49 2000 709 717
32. F. Rodríguez de Fonseca, M. Navarro, R. Gómez, L. Escudero, F. Nava, J. Fu, E. Murillo-Rodríguez, A. Giuffrida, J. LoVerme, S. Gaetani, S. Kathuria, C. Gali, and D. Piomelli An anorexic lipid mediator regulated by feeding Nature 414 2001 209 212
33. F. Rodríguez de Fonseca, M.A. Villanúa, R.M. Muñoz, O. San-Martin-Clark, and M. Navarro Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonist on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats Neuroendocrinology 61 1995 714 721
34. P.E. Sawchenko, and L.W. Swanson The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat J. Comp. Neurol. 218 1983 121 144
35. P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish A novel serum protein similar to C1q, produced exclusively in adipocytes J. Biol. Chem. 270 1995 26746 26749
36. M.W. Schwartz, S.C. Woods, D. Porte Jr., R.J. Seeley, and D.G. Baskin Central nervous system control of food intake Nature 404 2000 661 671
37. R.M. Señarís, F. Lago, R. Coya, J. Pineda, and C. Diéguez Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids Endocrinology 137 1996 5236 5241
38. A. Serrano, I. Del Arco, F.J. Pavón, M. Macías, V. Pérez-Valero, and F. Rodríguez de Fonseca The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats Neuropharmacology 54 2008 226 234
39. A. Serrano, J. Pavón, Y. De Diego, Y. Romero-Zerbo, F.J. Bermúdez-Silva, D. Bautista, D. Mayas, F. Rodríguez de Fonseca, and M. Macías Oleoylethanolamide, a ligand of the peroxisome proliferators - activated receptor alpha, prevents liver injury and oxidative stress induced by Tween 20 Obe. Metab. 4-1 2008 76 84
40. A. Serrano, J. Pavón, I. Del Arco, G. Rojo, M. Valenzuela, F.J. Bermúdez-Silva, F. Soriguer, and F. Rodríguez de Fonseca Oleoylethanolamide regulates level of fatty acid in rats via down regulation of liver desaturases mRNA expression Obe. Metab. 2-3 2006 155 164
41. A.M. Stutz, J. Staszkiewicz, A. Ptitsyn, and G. Argyropoulos Circadian expression of genes regulating food intake Obesity 15 2007 607 615
42. L. Walter, A. Franklin, A. Witting, T. Moller, and N. Stella Astrocytes in culture produce anandamide and other acylethanolamides J. Biol. Chem. 277 2002 20869 20876
43. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, and T. Kadowaki Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat. Med. 8 2002 1288 1295
44. Y. Zhang, M. Matheny, S. Zolotukhin, N. Tumer, and P.J. Scarpace Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting Biochim. Biophys. Acta 1584 2002 115 122
45. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432
46. J.M. Zigman, and J.K. Elmquist Minireview: from anorexia to obesity-the yin and yang of body weight control Endocrinology 2003 3749 3756